110 related articles for article (PubMed ID: 29419426)
1. Heterozygous carriers of germline c.657_661del5 founder mutation in
Tomasik B; Pastorczak A; Fendler W; Bartłomiejczyk M; Braun M; Mycko M; Madzio J; Polakowska E; Ulińska E; Matysiak M; Derwich K; Lejman M; Kowalczyk J; Badowska W; Kazanowska B; Szczepański T; Styczyński J; Irga-Jaworska N; Młynarski W;
Haematologica; 2018 May; 103(5):e200-e203. PubMed ID: 29419426
[No Abstract] [Full Text] [Related]
2. Germ line genetic NBN variation and predisposition to B-cell acute lymphoblastic leukemia in children.
Escherich CS; Chen W; Li Y; Yang W; Nishii R; Li Z; Raetz EA; Devidas M; Wu G; Nichols KE; Inaba H; Pui CH; Jeha S; Camitta BM; Larsen E; Hunger SP; Loh ML; Yang JJ
Blood; 2024 May; 143(22):2270-2283. PubMed ID: 38446568
[TBL] [Abstract][Full Text] [Related]
3. Heterozygous germ-line mutations in the NBN gene predispose to medulloblastoma in pediatric patients.
Ciara E; Piekutowska-Abramczuk D; Popowska E; Grajkowska W; Barszcz S; Perek D; Dembowska-Bagińska B; Perek-Polnik M; Kowalewska E; Czajńska A; Syczewska M; Czornak K; Krajewska-Walasek M; Roszkowski M; Chrzanowska KH
Acta Neuropathol; 2010 Mar; 119(3):325-34. PubMed ID: 19908051
[TBL] [Abstract][Full Text] [Related]
4. Association of the heterozygous germline I171V mutation of the NBS1 gene with childhood acute lymphoblastic leukemia.
Mosor M; Ziółkowska I; Pernak-Schwarz M; Januszkiewicz-Lewandowska D; Nowak J
Leukemia; 2006 Aug; 20(8):1454-6. PubMed ID: 16810201
[No Abstract] [Full Text] [Related]
5. The effect of central nervous system involvement and irradiation in childhood acute lymphoblastic leukemia: Lessons from the NOPHO ALL-92 and ALL-2000 protocols.
Taskinen M; Oskarsson T; Levinsen M; Bottai M; Hellebostad M; Jonsson OG; Lähteenmäki P; Schmiegelow K; Heyman M
Pediatr Blood Cancer; 2017 Feb; 64(2):242-249. PubMed ID: 27748030
[TBL] [Abstract][Full Text] [Related]
6. Cancer risk of heterozygotes with the NBN founder mutation.
Seemanová E; Jarolim P; Seeman P; Varon R; Digweed M; Swift M; Sperling K
J Natl Cancer Inst; 2007 Dec; 99(24):1875-80. PubMed ID: 18073374
[TBL] [Abstract][Full Text] [Related]
7. Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study.
Boer JM; Valsecchi MG; Hormann FM; Antić Ž; Zaliova M; Schwab C; Cazzaniga G; Arfeuille C; Cavé H; Attarbaschi A; Strehl S; Escherich G; Imamura T; Ohki K; Grüber TA; Sutton R; Pastorczak A; Lammens T; Lambert F; Li CK; Carrillo de Santa Pau E; Hoffmann S; Möricke A; Harrison CJ; Den Boer ML; De Lorenzo P; Stam RW; Bergmann AK; Pieters R
Leukemia; 2021 Oct; 35(10):2978-2982. PubMed ID: 34211097
[No Abstract] [Full Text] [Related]
8. Clinical outcome of childhood lymphoblastic lymphoma in Shanghai China 2001-2010.
Gao YJ; Pan C; Tang JY; Lu FJ; Chen J; Xue HL; Zhai XW; Li J; Ye QD; Zhou M; Wang HS; Miao H; Qian XW; Xu Z; Meng JH
Pediatr Blood Cancer; 2014 Apr; 61(4):659-63. PubMed ID: 24243691
[TBL] [Abstract][Full Text] [Related]
9.
Passet M; Boissel N; Sigaux F; Saillard C; Bargetzi M; Ba I; Thomas X; Graux C; Chalandon Y; Leguay T; Lengliné E; Konopacki J; Quentin S; Delabesse E; Lafage-Pochitaloff M; Pastoret C; Grardel N; Asnafi V; Lhéritier V; Soulier J; Dombret H; Clappier E;
Blood; 2019 Jan; 133(3):280-284. PubMed ID: 30510083
[No Abstract] [Full Text] [Related]
10. HMGA1 overexpression correlates with relapse in childhood B-lineage acute lymphoblastic leukemia.
Roy S; Di Cello F; Kowalski J; Hristov AC; Tsai HL; Bhojwani D; Meyer JA; Carroll WL; Belton A; Resar LM
Leuk Lymphoma; 2013 Nov; 54(11):2565-7. PubMed ID: 23472968
[No Abstract] [Full Text] [Related]
11. Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia.
Krentz S; Hof J; Mendioroz A; Vaggopoulou R; Dörge P; Lottaz C; Engelmann JC; Groeneveld TW; Körner G; Seeger K; Hagemeier C; Henze G; Eckert C; von Stackelberg A; Kirschner-Schwabe R
Leukemia; 2013 Feb; 27(2):295-304. PubMed ID: 22699455
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN
Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924
[TBL] [Abstract][Full Text] [Related]
13. 12p chromosomal aberrations in precursor B childhood acute lymphoblastic leukemia predict an increased risk of relapse in the central nervous system and are associated with typical blast cell morphology.
van der Plas DC; Dekker I; Hagemeijer A; Hooijkaas H; Hählen K
Leukemia; 1994 Dec; 8(12):2041-6. PubMed ID: 7807992
[TBL] [Abstract][Full Text] [Related]
14. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and outcome for children after second central nervous system relapse of acute lymphoblastic leukaemia.
Morris EC; Harrison G; Bailey CC; Hann IM; Hill FG; Gibson BE; Richards S; Webb DK;
Br J Haematol; 2003 Mar; 120(5):787-9. PubMed ID: 12614210
[TBL] [Abstract][Full Text] [Related]
16. Cysteine and glycine-rich protein 2 (CSRP2) transcript levels correlate with leukemia relapse and leukemia-free survival in adults with B-cell acute lymphoblastic leukemia and normal cytogenetics.
Wang SJ; Wang PZ; Gale RP; Qin YZ; Liu YR; Lai YY; Jiang H; Jiang Q; Zhang XH; Jiang B; Xu LP; Huang XJ; Liu KY; Ruan GR
Oncotarget; 2017 May; 8(22):35984-36000. PubMed ID: 28415593
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of hematopoietic stem cell transplantation and prophylactic triple intrathecal therapy in a child with multiple CNS relapse of acute lymphoblastic leukemia.
Tavil B; Ayçicek A; Azik F; Tunc B; Del Castello BE; Uçkan D
Clin Transplant; 2013; 27(4):E346-7. PubMed ID: 23781848
[No Abstract] [Full Text] [Related]
18. Germline PAX5 mutation predisposes to familial B-cell precursor acute lymphoblastic leukemia.
Duployez N; Jamrog LA; Fregona V; Hamelle C; Fenwarth L; Lejeune S; Helevaut N; Geffroy S; Caillault A; Marceau-Renaut A; Poulain S; Roche-Lestienne C; Largeaud L; Prade N; Dufrechou S; Hébrard S; Berthon C; Nelken B; Fernandes J; Villenet C; Figeac M; Gerby B; Delabesse E; Preudhomme C; Broccardo C
Blood; 2021 Mar; 137(10):1424-1428. PubMed ID: 33036026
[No Abstract] [Full Text] [Related]
19. CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment.
Mejstríková E; Hrusak O; Borowitz MJ; Whitlock JA; Brethon B; Trippett TM; Zugmaier G; Gore L; von Stackelberg A; Locatelli F
Blood Cancer J; 2017 Dec; 7(12):659. PubMed ID: 29259173
[No Abstract] [Full Text] [Related]
20. The frequency of NBN molecular variants in pediatric astrocytic tumors.
Piekutowska-Abramczuk D; Ciara E; Popowska E; Grajkowska W; Dembowska-Bagińska B; Kowalewska E; Czajńska A; Perek-Polnik M; Roszkowski M; Syczewska M; Krajewska-Walasek M; Perek D; Chrzanowska KH
J Neurooncol; 2010 Jan; 96(2):161-8. PubMed ID: 19629396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
